| pubmed-article:20697094 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C0079773 | lld:lifeskim |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C1527027 | lld:lifeskim |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
| pubmed-article:20697094 | lifeskim:mentions | umls-concept:C1512888 | lld:lifeskim |
| pubmed-article:20697094 | pubmed:issue | 29 | lld:pubmed |
| pubmed-article:20697094 | pubmed:dateCreated | 2010-10-8 | lld:pubmed |
| pubmed-article:20697094 | pubmed:abstractText | The primary objective of this study was to confirm the efficacy of romidepsin in patients with treatment refractory cutaneous T-cell lymphoma (CTCL). | lld:pubmed |
| pubmed-article:20697094 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20697094 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20697094 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20697094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20697094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20697094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20697094 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20697094 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:20697094 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:BeckerJürgen... | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:DuvicMadelein... | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:LernerAdamA | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:RookAlain HAH | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:WhittakerSean... | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:KimYoun HYH | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:RobakTadeuszT | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:DemierreMarie... | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:ScarisbrickJu... | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:KimEllen JEJ | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:ReddySunilS | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:McCullochWill... | lld:pubmed |
| pubmed-article:20697094 | pubmed:author | pubmed-author:SamtsovAlexey... | lld:pubmed |
| pubmed-article:20697094 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20697094 | pubmed:day | 10 | lld:pubmed |
| pubmed-article:20697094 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:20697094 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20697094 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20697094 | pubmed:pagination | 4485-91 | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:meshHeading | pubmed-meshheading:20697094... | lld:pubmed |
| pubmed-article:20697094 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20697094 | pubmed:articleTitle | Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. | lld:pubmed |
| pubmed-article:20697094 | pubmed:affiliation | Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom. sean.whittaker@kcl.ac.uk | lld:pubmed |
| pubmed-article:20697094 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20697094 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20697094 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20697094 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20697094 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20697094 | lld:pubmed |
